e-learning
resources
Munich 2014
Sunday, 07.09.2014
Markers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
S. Daiana, A. Meyer, J. Rakic, L. Boeck, A. Scherr, M. Tamm (Basel, Switzerland)
Source:
International Congress 2014 – Markers
Session:
Markers
Session type:
Thematic Poster Session
Number:
564
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Daiana, A. Meyer, J. Rakic, L. Boeck, A. Scherr, M. Tamm (Basel, Switzerland). Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up. Eur Respir J 2014; 44: Suppl. 58, 564
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Stable state MR-proadrenomedullin level in COPD patients; a validation study
Source: International Congress 2014 – Comorbidities
Year: 2014
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014
Adrenomedullin optimizes mortality prediction in COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Mortality risk prediction in COPD by a prognostic biomarker panel
Source: Eur Respir J 2014; 44: 1557-1570
Year: 2014
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Simple functional performance tests as predictors of clinical outcomes in COPD
Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases
Year: 2015
Mortality predictors in stable COPD
Source: International Congress 2014 – Predictors
Year: 2014
Risk scores for predicting death in COPD patients
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Detecting undiagnosed COPD: Using routine primary care data to select and validate candidate variables for COPD risk prediction
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013
Clinical phenotyping of COPD patients: a simple tool with prognosis value
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
SP-D as a biomarker for COPD in the Lebanese population
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score
Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept